By Marathon Money Team
Austin, Texas and New York
MedX Holdings, trading under OTC: MEDH, reported meaningful operational progress and more than 100% year over year revenue growth in its most recent quarter. The company is positioning itself for broader expansion in 2026, driven by franchising momentum, improved financial controls, and a potential regulatory catalyst coming from Washington.
In an exclusive interview with Marathon Money, CEO Hans Enriquez discussed the company’s financial turnaround, the growth of the LazyDaze + Coffeeshop franchise model, and the path toward scaling operations in multiple states. The conversation came on the same day that President Trump announced an intention to cut federal regulations on marijuana, a policy signal that could reshape the entire cannabis retail landscape. The news quickly captured attention across the industry and supports the strategic direction MedX Holdings has been building toward.
Strong Revenue Growth and Return to Operating Profit
According to filings on the OTC Markets platform, MedX Holdings generated $568,177 in revenue in Q3 2025, a 130% increase from the same quarter last year. Year to date revenue reached approximately $1.29 million. The company also reported a return to positive operating income both for the quarter and year to date.
Shares of MedX Holdings trade near $0.0007, with a market capitalization below $1 million. Public data shows approximately 690 million shares outstanding and a float of about 683 million, which places MEDH firmly in the microcap category. Liquidity remains low, but operational growth has begun to shift investor sentiment around the long term potential of the business.
Franchise Expansion and Las Vegas Flagship
MedX Holdings secured five franchise agreements across Texas and Maryland, strengthening its footprint in states where consumer demand and regulatory frameworks are better aligned. The company is also advancing a corporate owned flagship location in Las Vegas, which the CEO described as a proving ground for systems, branding, and experiential retail that can later be replicated across franchise markets.
The CEO noted that franchise openings generally follow a timeline of several months to more than a year, depending on permits, build outs, and training. He emphasized that MedX Holdings is focusing on infrastructure and compliance so franchise partners have a clean operational runway once stores open to the public.
Regulatory Catalyst: Trump Administration Signals Marijuana Reform
A new development that could have meaningful implications for MedX Holdings is President Trump’s public move to reduce federal regulations surrounding marijuana. During the interview, CEO Hans Enriquez discussed how regulatory clarity and reduced federal pressure would accelerate both franchising and compliant retail operations.
Today’s news reinforced that conversation. Trump’s position suggests potential easing of federal restrictions, a shift that may support state compliant operators like MedX Holdings while reducing barriers to banking, insurance, and interstate expansion. Companies that have positioned themselves within regulated frameworks instead of loophole driven models appear to be best positioned to benefit.
For MedX Holdings, which has intentionally avoided gray area products and structures, this could serve as a significant tailwind in 2025 and 2026.
Analyst Outlook and 2026 Forecast
From an investment standpoint, MedX Holdings remains speculative but increasingly structured. It has transitioned from survival toward early growth. The combination of revenue acceleration, return to operating profit, tighter internal controls, and an expanding franchise base provides a stronger foundation than the company has had in years.
If MedX continues to execute its plan, completes the Las Vegas flagship, and brings additional franchise units online, the business has the potential to scale into the multi million dollar revenue range in 2026. This is the threshold where microcap companies often begin to attract early stage institutional attention.
A regulatory shift under the Trump administration would further expand the addressable market for MedX Holdings, reduce compliance friction, and increase the odds of national brand positioning for LazyDaze + Coffeeshop.
Our analyst expectation:
If current progress continues, MedX Holdings could trade meaningfully higher in 2026 as revenue increases and regulatory clarity improves. Execution remains the key variable.
Conclusion
MedX Holdings (OTC: MEDH) is evolving from a small scale OTC lifestyle brand into a structured, compliance driven franchise company with expanding revenue and a long term strategic plan. As both the cannabis regulatory environment and consumer market shift, MedX is positioning itself as a disciplined operator built for regulated expansion rather than quick arbitrage.
Investors should monitor franchise openings, the Las Vegas flagship performance, federal regulatory movement, and liquidity as the next indicators of value creation.
Subscribe to Marathon Money for full coverage.
Watch the complete CEO interview on YouTube at Marathon Money or listen on Apple Podcasts, Spotify, Pandora, and 15 other platforms.
Podcast: Play in new window | Download
Discover more from Marathon Money +
Subscribe to get the latest posts sent to your email.